Unknown

Dataset Information

0

Impact of Perioperative Dry Eye Treatment with Rebamipide Versus Artificial Tears on Visual Outcomes After Cataract Surgery in Japanese Population.


ABSTRACT:

Introduction

The present study aimed to compare the effects of rebamipide and artificial tears during the perioperative period of cataract surgery on the postoperative visual outcomes.

Methods

Seventy-two eyes from 36 patients with a cataract were enrolled. Rebamipide (group R) was administered in one eye and Mytear® artificial tear ophthalmic solution (group A) in the other eye from 4 weeks preoperatively to 3 months postoperatively. Tear breakup time (TBUT), high-order aberrations (HOAs), superficial punctate keratopathy in the central part of the cornea (C-SPK), and corrected distance visual acuity (CDVA) were assessed at baseline, 1 week, 1 month, and 3 months after cataract surgery with trifocal intraocular lens (IOL) implantation. Contrast sensitivity and disability glare with visual angle values compatible with spatial frequencies of 1.1, 1.8, 2.9, 4.5, 7.1, and 10.2 cycles/degree (CPD) were evaluated postoperatively. Between-group differences of all variables were analyzed.

Results

At baseline, no significant differences in the variables were noted between the two groups. Mean TBUT was significantly higher, while mean C-SPK and HOAs were significantly lower in group R than in group A at each assessment. Mean CDVA was significantly higher at 1 week and 1 month postoperatively in group R compared with group A; this value was not significant at 3 months. Between-group differences in contrast sensitivity and disability glare were statistically significant at all spatial frequencies, 1 week and 1 month postoperatively. At 3 months postoperatively, there were significant differences in contrast sensitivity and disability glare at most spatial frequencies.

Conclusion

Dry eye management with rebamipide in the perioperative period of cataract surgery with trifocal IOL implantation was significantly more effective than artificial tears in improving ocular surface condition, contrast sensitivity, and disability glare postoperatively.

SUBMITTER: Teshigawara T 

PROVIDER: S-EPMC9253222 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5991988 | biostudies-literature
| S-EPMC8295542 | biostudies-literature
| S-EPMC9572360 | biostudies-literature
| S-EPMC6218275 | biostudies-literature
| S-EPMC8035101 | biostudies-literature
| S-EPMC7076486 | biostudies-literature
| S-EPMC7502384 | biostudies-literature
| S-EPMC10800283 | biostudies-literature
| S-EPMC10775660 | biostudies-literature
| S-EPMC6093252 | biostudies-literature